Defining Which Remission Criterion At Month 6 Predicts Remission At Month 12 In A Real Life Clinical Practice, In A Cohort Of Rheumatoid Arthritis Patients Treated With Etanercept (Enbrel (Registered))
Phase of Trial: Phase IV
Latest Information Update: 29 May 2017
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms REACH RA
- Sponsors Pfizer
- 10 Jun 2017 Biomarkers information updated
- 24 May 2017 Status changed from recruiting to completed.
- 11 Apr 2017 Planned End Date changed from 31 Mar 2017 to 30 Apr 2017.